Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • Webcasts
  • Data Privacy
  • Français
  • my CNW 
    • Login
    • Register
  • Client Login 
    • Online Member Centre
    • Next Gen Communications Cloud
    • Cision Communications Cloud®
  • Sign Up
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
Advanced Search
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Canadian Federal Government
      • Canadian Municipal Government
      • Canadian Provincial Government
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

  • Advanced Search
  • Overview
  • Multichannel Amplification
  • Monitoring
  • Distribution
  • Multimedia
  • Guaranteed Paid Placement
  • AI Tools
  • IR
  • Become a Client
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • General Enquiries
  • Media
  • Worldwide Offices
  • Hamburger menu
  • Cision Canada
  • Send a Release
  • FR
    • Phone

    • 877-269-7890 from 8 AM - 10 PM ET

    • ALL CONTACT INFO
    • Contact Cision

      877-269-7890
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Resources
  • Blog
  • Journalists
  • Webcasts
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign Up
  • Resources
  • Blog
  • Journalists
  • Webcasts
  • GDPR
  • Overview
  • Multichannel Amplification
  • Monitoring
  • Distribution
  • Multimedia
  • Guaranteed Paid Placement
  • AI Tools
  • IR
  • Send a Release
  • Sign Up
  • Resources
  • Blog
  • Journalists
  • Webcasts
  • GDPR
  • Become a Client
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • General Enquiries
  • Media
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Resources
  • Blog
  • Journalists
  • Webcasts
  • GDPR

Harper Government invests in childhood cancer research Français


News provided by

Canadian Institutes of Health Research

Apr 11, 2012, 11:15 ET

Share this article

Share toX

Share this article

Share toX

TORONTO, ON, April 11, 2012 /CNW/ - The Honourable Leona Aglukkaq, Minister of Health, today announced funding from the Harper Government and partners to support research that aims to protect the long-term health of childhood cancer survivors.

"Our Government is committed to ensuring that childhood cancer patients receive the most effective and appropriate treatments available to them," said Minister Aglukkaq. "Our goal is to improve the health and quality of life for children who survive cancer."

Funding from Government of Canada, through the Canadian Institutes of Health Research (CIHR) and six leading cancer organizations will support four new research teams: two based at The Hospital for Sick Children (Sick Kids) in Toronto, one based at the Child & Family Research Institute at the BC Children's Hospital in Vancouver, and another one in Montreal at the Sainte-Justine University Hospital Center. These teams will look for ways to reduce the harmful effects of cancer treatment on children, including damage to the brain, heart and other major organs. This highly committed group of researchers all share the same goal: to improve cancer treatment for the benefit of Canadians.

CIHR has partnered with the following organizations to support this initiative: Garron Family Cancer Centre at Sick Kids, C17 Council, Canadian Cancer Society, Cancer Research Society, Ontario Institute for Cancer Research and Pediatric Oncology Group of Ontario.

"As Canada's leading paediatric academic health-care centre, SickKids sees firsthand the devastating impact cancer can have on children and their families," says Mary Jo Haddad, SickKids President and CEO. "Through the funding from this important initiative, SickKids researchers can continue improving cancer treatments for Canada's children and youth that will enhance the quality of life for paediatric cancer patients."

Please see Fact Sheet for more information

The Canadian Institutes of Health Research (CIHR) is the Government of Canada's health research investment agency. CIHR's mission is to create new scientific knowledge and to enable its translation into improved health, more effective health services and products, and a strengthened Canadian health care system. Composed of 13 Institutes, CIHR provides leadership and support to more than 14,100 health researchers and trainees across Canada. www.cihr-irsc.gc.ca

Fact Sheet

Background - The Health Issue

According to the Canadian Cancer Statistics 2011, 6,550 children between the ages of 0-19 were diagnosed with cancer between 2003 and 2007, just one percent of the total cancer diagnoses in Canada. Although the numbers are small relative to adult cancer, 82% of these children now survive their disease, and it is estimated that more than 30,000 Canadians are now childhood cancer survivors.

Although childhood cancer is a relatively rare disease and the outcomes have improved dramatically in recent years, a large percentage of pediatric cancer patients develop multiple, serious, and sometimes fatal, health effects as a result of their cancer treatments. The list of these long-term adverse effects, or "late effects", is long and includes damage to the central nervous system, senses and major organs, such as heart, kidneys and lungs. The risk of developing second cancers is also elevated in childhood cancer survivors. It is estimated that more than 60% of survivors suffer from at least one chronic condition and almost 30% have severe or life-threatening conditions. Unfortunately the incidence and severity of these chronic conditions appears to increase over time.

Frequently these late effects are diagnosed and treated by physicians working in the adult domain, often with no prior knowledge of the previous cancer treatments. In order to prevent or mitigate the subsequent late effects, a dialogue is needed between pediatric oncologists and the clinicians in other disciplines, such as cardiology, neurology, endocrinology and oncology (for second cancers), responsible for treating survivors who experience the late effects, sometimes decades after the primary treatments.

Late Effects of Childhood Cancer Treatment -New Research Teams

To address these medical needs, the Government of Canada, through the Canadian Institutes of Health Research, has invested $12 million over five years to support four new research teams in partnership with the C17 council, the Canadian Cancer Society, the Cancer Research Society, Garron Family Cancer Centre at The Hospital for Sick Children, the Ontario Institute for Cancer Research and the Pediatric Oncology Group of Ontario.

The four successful teams are:

Nominated Principal Investigator Co-Principal Investigators Title and Description of Project Funding
Shinya Ito
Hospital for Sick Children
Sharon Guger
Johann H Hitzler
Deborah L O'Connor
Russell J Schachar
Brenda Spiegler
Rosanna Weksberg
Neurocognitive-Phenome, Genome, Epigenome and Nutriome In Childhood leukemia Survivors: N-PhenoGENICS

Dr. Ito's team will study how childhood leukemia treatment affects brain function, particularly attention deficit disorder, which can remain for a long time and have an impact on children's academic performance and social activity. The team will study the factors that make some children more susceptible to this effect and explore mitigation strategies. Recent reports suggest that mutation of a gene involved in metabolism of the vitamin folate, is responsible. This study aims to discover if not only this gene but also other related genes are associated with this damage. If the responsible genes are found, the team will explore a strategy to avoid this side effect.
$1.9M
Paul Nathan
Hospital For Sick Children
Paul F. Kantor
Peter P. Liu
Luc Mertens
Seema Mital
Novel approaches to the prediction, diagnosis and treatment of cardiac late effects of childhood cancer.

Dr. Nathan's team will study cardiotoxicity and evaluate the importance of genetic differences between individuals in determining who is at greatest risk of developing heart disease as a result of exposure to chemotherapeutic agents. The team brings together several integrated research cores to test new imaging and biomarker methods with the ultimate aim of earlier detection of heart disease before clinical symptoms develop or it becomes apparent on standard imaging tests. Vulnerable children can then be targeted, by modifying their cancer therapy, or by introducing medications that protect the heart from chemotherapy damage.
$2.8M
Kirk Schultz
Child & Family Research Institute at BC Children's Hospital and the University of British Columbia
Sylvain Baruchel
Mary L McBride
Lesley G Mitchell
Shahrad G Rassekh
Ross T Tsuyuki
Michele Zappitelli
Applying Biomarkers to Long-term Effects in Child and Adolescent Cancer Treatment (ABLE Team)

Dr. Schultz's team will assess biomarkers to identify children at risk of adverse effects of their successful cancer treatments, and to predict the course of development of their long-term complications. Identifying these high-risk children will lead to preemptive and timely therapies to minimize or eliminate these effects. Studies will focus on biomarkers associated with hearing loss, kidney failure, blood clotting problems, and a specific form of tissue rejection called chronic graft-versus host disease after hematopoietic transplantation used to treat cancer. The studies include 8 pediatric centers across Canada.
$4.3M
Daniel Sinnett
Sainte-Justine University Hospital Centre
Nathalie B Alos
Gregor U Andelfinger,
Maja Krajinovic
Caroline Laverdière
Emile Levy
Philippe Robaey
Genomic determinants of common long-term treatment effects in childhood acute lymphoblastic leukemia survivors

Dr. Sinnett's team will focus on acute lymphoblastic leukemia (ALL), the most frequent cancer in children. Roughly 80% of cases can be cured with current treatment protocols. More than two-thirds of the survivors experience chronic or late-occurring health problems, often not clinically apparent until decades after treatment. The team will study ways to prevent or mitigate treatment related toxicities in a subset of the most common late-occurring adverse effects observed in childhood ALL survivors, including neurocognitive effects, metabolic syndrome, cardiotoxicity and bone morbidity.
$3M

Media Enquiries:

Cailin Rodgers
Office of the Honourable Leona Aglukkaq
613-957-0200

David Coulombe
Media Relations
Canadian Institutes of Health Research
613-941-4563

[email protected]

Modal title

Organization Profile

Canadian Institutes of Health Research

Related Organization(s)

Government of Canada

    Also from this source

  • Readout - Prime Minister Carney speaks with President of Chile Gabriel Boric

  • /R E P E A T -- Media Advisory - Minister Hodgson to Announce Carbon Management Funding in Alberta/

  • Fisheries and Oceans Canada partners with the Manitoba Government to conduct an aquatic invasive species roadside inspection blitz

Contact Cision

  • 866-245-2317
    from 8 AM - 10 PM ET
  • Become a Client
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • General Enquiries
  • Media

Products

  • Cision Communications Cloud®
  • Media Monitoring
  • Content Distribution
  • Multimedia Distribution
  • Measurement & Analytics
  • Investor Relations

About

  • About Cision Canada
  • About Cision
  • Media Partners
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Online Member Centre
  • Next Gen Communications Cloud
  • Cision Communications Cloud®
  • my CNW

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Centre
  • Next Gen Communications Cloud
  • Cision Communications Cloud
  • my CNW
877-269-7890
from 8 AM - 10 PM ET
  • Terms of Use
  • Information Security Policy
  • Site Map
  • Cookie Settings
  • Accessibility Statement
Copyright © 2025 CNW Group Ltd. All Rights Reserved. A Cision company.